Reply to the Letter to the Editor Regarding the Study “The Effectiveness of Gabapentin and Gabapentin/Montelukast Combination Compared With Dextromethorphan in the Improvement of Covid-19-Related Cough: A Randomized, Controlled Clinical Trial”

Reply to the Letter to the Editor Regarding the Study “The Effectiveness of Gabapentin and Gabapentin/Montelukast Combination Compared With Dextromethorphan in the Improvement of Covid-19-Related Cough: A Randomized, Controlled Clinical Trial” Publisher Pubmed

Hakamifard A^{1, 2} ; Soltani R^{3, 4}

Show Affiliations

1. Department of Infectious Diseases, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2. Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3. Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
4. Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Clinical Respiratory Journal Published:2023

Abstract

[No abstract available]

Style	Citing Format
MLA	Hakamifard A, Soltani R. "Reply to the Letter to the Editor Regarding the Study “The Effectiveness of Gabapentin and Gabapentin/Montelukast Combination Compared With Dextromethorphan in the Improvement of Covid-19-Related Cough: A Randomized, Controlled Clinical Trial”." Clinical Respiratory Journal, vol. 17, no. 6, 2023, pp. 603-604.
APA	Hakamifard A, Soltani R (2023). Reply to the Letter to the Editor Regarding the Study “The Effectiveness of Gabapentin and Gabapentin/Montelukast Combination Compared With Dextromethorphan in the Improvement of Covid-19-Related Cough: A Randomized, Controlled Clinical Trial”. Clinical Respiratory Journal, 17(6), 603-604.
Chicago	Hakamifard A, Soltani R. "Reply to the Letter to the Editor Regarding the Study “The Effectiveness of Gabapentin and Gabapentin/Montelukast Combination Compared With Dextromethorphan in the Improvement of Covid-19-Related Cough: A Randomized, Controlled Clinical Trial”." Clinical Respiratory Journal 17, no. 6 (2023): 603-604.
Harvard	Hakamifard A, Soltani R (2023) 'Reply to the Letter to the Editor Regarding the Study “The Effectiveness of Gabapentin and Gabapentin/Montelukast Combination Compared With Dextromethorphan in the Improvement of Covid-19-Related Cough: A Randomized, Controlled Clinical Trial”', Clinical Respiratory Journal, 17(6), pp. 603-604.
Vancouver	Hakamifard A, Soltani R. Reply to the Letter to the Editor Regarding the Study “The Effectiveness of Gabapentin and Gabapentin/Montelukast Combination Compared With Dextromethorphan in the Improvement of Covid-19-Related Cough: A Randomized, Controlled Clinical Trial”. Clinical Respiratory Journal. 2023;17(6):603-604.
BibTex	@article{ author = {Hakamifard A and Soltani R}, title = {Reply to the Letter to the Editor Regarding the Study “The Effectiveness of Gabapentin and Gabapentin/Montelukast Combination Compared With Dextromethorphan in the Improvement of Covid-19-Related Cough: A Randomized, Controlled Clinical Trial”}, journal = {Clinical Respiratory Journal}, volume = {17}, number = {6}, pages = {603-604}, year = {2023} }
RIS	TY - JOUR AU - Hakamifard A AU - Soltani R TI - Reply to the Letter to the Editor Regarding the Study “The Effectiveness of Gabapentin and Gabapentin/Montelukast Combination Compared With Dextromethorphan in the Improvement of Covid-19-Related Cough: A Randomized, Controlled Clinical Trial” JO - Clinical Respiratory Journal VL - 17 IS - 6 SP - 603 EP - 604 PY - 2023 ER -

Style

Citing Format

MLA

Hakamifard A, Soltani R. "Reply to the Letter to the Editor Regarding the Study “The Effectiveness of Gabapentin and Gabapentin/Montelukast Combination Compared With Dextromethorphan in the Improvement of Covid-19-Related Cough: A Randomized, Controlled Clinical Trial”." Clinical Respiratory Journal, vol. 17, no. 6, 2023, pp. 603-604.

APA

Hakamifard A, Soltani R (2023). Reply to the Letter to the Editor Regarding the Study “The Effectiveness of Gabapentin and Gabapentin/Montelukast Combination Compared With Dextromethorphan in the Improvement of Covid-19-Related Cough: A Randomized, Controlled Clinical Trial”. Clinical Respiratory Journal, 17(6), 603-604.

Chicago

Harvard

Hakamifard A, Soltani R (2023) 'Reply to the Letter to the Editor Regarding the Study “The Effectiveness of Gabapentin and Gabapentin/Montelukast Combination Compared With Dextromethorphan in the Improvement of Covid-19-Related Cough: A Randomized, Controlled Clinical Trial”', Clinical Respiratory Journal, 17(6), pp. 603-604.

Vancouver

Hakamifard A, Soltani R. Reply to the Letter to the Editor Regarding the Study “The Effectiveness of Gabapentin and Gabapentin/Montelukast Combination Compared With Dextromethorphan in the Improvement of Covid-19-Related Cough: A Randomized, Controlled Clinical Trial”. Clinical Respiratory Journal. 2023;17(6):603-604.

BibTex

@article{ author = {Hakamifard A and Soltani R}, title = {Reply to the Letter to the Editor Regarding the Study “The Effectiveness of Gabapentin and Gabapentin/Montelukast Combination Compared With Dextromethorphan in the Improvement of Covid-19-Related Cough: A Randomized, Controlled Clinical Trial”}, journal = {Clinical Respiratory Journal}, volume = {17}, number = {6}, pages = {603-604}, year = {2023} }

RIS

TY - JOUR
AU - Hakamifard A
AU - Soltani R
TI - Reply to the Letter to the Editor Regarding the Study “The Effectiveness of Gabapentin and Gabapentin/Montelukast Combination Compared With Dextromethorphan in the Improvement of Covid-19-Related Cough: A Randomized, Controlled Clinical Trial”
JO - Clinical Respiratory Journal
VL - 17
IS - 6
SP - 603
EP - 604
PY - 2023
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract